Atara Biotherapeutics' Collaborating Investigators to Present Data at the American Society of Hematology Annual Meeting 2014 Nov 06, 2014 9:05am EST
Atara Biotherapeutics Doses First Patient in Phase 1 Clinical Study of STM 434, an Activin Inhibitor Oct 22, 2014 6:50am EDT
Atara Biotherapeutics Announces Immunotherapy Alliance With Memorial Sloan Kettering Cancer Center Sep 23, 2014 9:00am EDT
Atara Biotherapeutics Announces Second Closing of $52 Million Series B Financing Jan 10, 2014 7:00am EST
